Bangladesh Final Registration: Original Documents and Embassy Attestation

1. Key takeaways

The second step of Bangladesh registration — Final Registration — requires submissions in original form, not copies: the original Free Sale Certificate (CFS) attested by the Embassy of Bangladesh in the issuing country, and the original physical empty packaging boxes and empty labels. The PDFs or photocopies accepted at step one do not count at step two. Beyond the official final review period of 30–40 days, this is the segment of physical logistics time most frequently left out of project schedules.

• The final review requires the original CFS: Original FSC attested by the Bangladesh Embassy (registration practice consolidation, practical estimate).
• The final review requires the original empty boxes and labels: packaging materials in blank form — Box, Label, IFU (practical estimate).
• Label elements: the label must reflect the brand and manufacturer name, country of origin, manufacturing date, expiry date and batch number (practical estimate).
• Labelling rules: labelling follows ISO standards and GHTF/SG1/N70:2011; symbols follow ISO 15223-1:2007; the manufacturing date or expiry date (or both) must be marked, per §7.2 of the DGDA Medical Device Registration Guidelines.
• Sampling and verification: sampling follows the prescribed procedure; where necessary, DGDA may adopt other verification measures, per §4.9 of the same Guidelines.
• Final review period: 30–40 days officially (a practical estimate of 2–3 months).

2. Legal basis

The table below consolidates the basis for the original-document requirement. The requirement itself and the timing figures rest on registration practice, while the labelling content of the original packaging is anchored in §7.2 of the DGDA Medical Device Registration Guidelines and the sampling verification in §4.9. Read together, they show that step two is a physical, evidence-based examination rather than a document-scanning exercise.

3. Expert insights

Insight one: clearing step one with PDFs and clearing step two with originals are two different tasks, and most companies prepare only the first. PDFs and photocopies may serve at step one, but step two requires originals. Many companies treat the PDF as the endpoint, and only after receiving the recipe approval letter do they discover that a fresh round of embassy attestation and international courier work lies ahead. This leg of the journey must be completed while step one is still under review; otherwise the waiting time created by the quarterly meeting cycle is wasted entirely. The correct reading of the two-step design is that step one is the trigger to start the original-document pipeline, not the moment to rest.

Insight two: the original empty boxes and labels are physical evidence, not documents. DGDA judges label conformity with §7.2 through the physical items themselves. All three items — empty box, label, and instructions for use — are required, and they must be in a blank, unused state. This means the manufacturer must arrange a dedicated packaging proofing and shipment round for registration purposes. For companies with tight production capacity or long packaging lead times, this is a hidden prerequisite item that does not appear on any standard document checklist but can hold up the final submission just as effectively as a missing certificate.

Insight three: the mandatory label elements are stated explicitly in the Guidelines, so do not improvise. Note 1 to §7.2 requires the manufacturing date or expiry date (or both) to be marked, and Note 2 provides that labelling information for bulk packs is marked on the bulk packaging. The practical checklist additionally requires the brand, the manufacturer name, the country of origin, and the batch number. These six items together form the compliance baseline: if any one of them is missing, the label will be judged non-conforming. Custom label designs that look elegant but drop one of these elements convert a marketing improvement into a registration failure.

4. Practical recommendations

• Manage the “original document package” as an independent deliverable with its own owner and timeline, separate from the dossier text itself.
• Start the embassy attestation of the original CFS on the very day of the step-one submission, rather than waiting for the recipe approval letter.
• Ask the client to ship the blank packaging originals — empty boxes, labels and IFU — to the Bangladesh local partner for safekeeping while step one is under review.
• Conduct an unboxing verification before the final submission: check the embassy stamps on the original CFS item by item, and verify the empty box originals and all six label elements before filing.
• Do not leave the original documents until after the recipe approval letter has been issued; doing so stacks two serial lead times on top of each other.
• Plan the final submission schedule around the 30–40 day official period, using a practical estimate of 2–3 months for internal commitments.

5. Verification checklist

• □ The embassy attestation of the original CFS has been started during step one
• □ The original empty box, label and IFU have arrived in Bangladesh and are properly stored
• □ The six label elements have been checked: brand, manufacturer name, country of origin, manufacturing date, expiry date, batch number
• □ The label conforms to §7.2 (ISO/GHTF labelling, ISO 15223-1 symbols, manufacturing or expiry date)
• □ For Class C/D, both the country-of-origin and reference-country CFS originals have been prepared
• □ The final submission date has been scheduled against the 30–40 day period (practical estimate 2–3 months)

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including Bangladesh. Our team prepares dossiers to DGDA expectations, manages submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Regulatory information verified as of October 27, 2026.